Authors:
Salmena, L
Lam, V
McPherson, JP
Goldenberg, GJ
Citation: L. Salmena et al., Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase II alpha expression, BIOCH PHARM, 61(7), 2001, pp. 795-802
Authors:
Vanlingen, S
Sipma, H
De Smet, P
Callewaert, G
Missiaen, L
De Smedt, H
Parys, JB
Citation: S. Vanlingen et al., Modulation of inositol 1,4,5-trisphosphate binding to the various inositol1,4,5-trisphosphate receptor isoforms by thimerosal and cyclic ADP-ribose, BIOCH PHARM, 61(7), 2001, pp. 803-809
Citation: T. Sanchez et Jj. Moreno, The effect of high molecular phospholipase A(2) inhibitors on 3T6 fibroblast proliferation, BIOCH PHARM, 61(7), 2001, pp. 811-816
Authors:
Agasosler, AV
Tungodden, LM
Cejka, D
Bakstad, E
Sydnes, LK
Holmsen, H
Citation: Av. Agasosler et al., Chorpromazine-induced increase in dipalmitoylphosphatidylserine surface area in monolayers at room temperature, BIOCH PHARM, 61(7), 2001, pp. 817-825
Authors:
de la Rosa, LA
Alfonso, A
Vilarino, N
Vieytes, MR
Botana, LM
Citation: La. De La Rosa et al., Modulation of cytosolic calcium levels of human lymphocytes by yessotoxin,a novel marine phycotoxin, BIOCH PHARM, 61(7), 2001, pp. 827-833
Citation: G. Vazeux et al., Potency and selectivity of RXP407 on human, rat, and mouse angiotensin-converting enzyme, BIOCH PHARM, 61(7), 2001, pp. 835-841
Authors:
Zaccaro, C
Sweitzer, S
Pipino, S
Gorman, N
Sinclair, PR
Sinclair, JF
Nebert, DW
De Matteis, F
Citation: C. Zaccaro et al., Role of cytochrome P450 1A2 in bilirubin degradation - Studies in Cyp1a2 (-/-) mutant mice, BIOCH PHARM, 61(7), 2001, pp. 843-849
Citation: S. Di Bartolomeo et A. Spinedi, Potentiation of okadaic acid-induced ceramide elevation but not apoptosis by inhibition of glucosylceramide synthase in human neuroepithelioma cells, BIOCH PHARM, 61(7), 2001, pp. 851-856
Citation: Rb. Zhao et al., Marked suppression of the activity of some, but not all, antifolate compounds by augmentation of folate cofactor pools within tumor cells, BIOCH PHARM, 61(7), 2001, pp. 857-865
Authors:
Machover, D
Zittoun, J
Broet, P
Metzger, G
Orrico, M
Goldschmidt, E
Schilf, A
Tonetti, C
Tan, YY
Delmas-Marsalet, B
Luccioni, C
Falissard, B
Hoffman, RM
Citation: D. Machover et al., Cytotoxic synergism of methioninase in combination with 5-fluorouracil andfolinic acid, BIOCH PHARM, 61(7), 2001, pp. 867-876
Authors:
Shankar, VN
Byford, V
Prosser, DE
Schroeder, NJ
Makin, HLJ
Wiesinger, H
Neef, G
Steinmeyer, A
Jones, G
Citation: Vn. Shankar et al., Metabolism of a 20-methyl substituted series of vitamin D analogs by cultured human cells: apparent reduction of 23-hydroxylation of the side chain by the 20-methyl group, BIOCH PHARM, 61(7), 2001, pp. 893-902
Authors:
Kim, EJ
Jin, HK
Kim, YK
Lee, HY
Lee, SY
Lee, KR
Zee, OP
Han, JW
Lee, HW
Citation: Ej. Kim et al., Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-kappa B activation, BIOCH PHARM, 61(7), 2001, pp. 903-910
Citation: Y. Ikeda et al., Evidence for bradykinin mediation of carrageenin-induced inflammatory pain: a study using kininogen-deficient Brown Norway Katholiek rats, BIOCH PHARM, 61(7), 2001, pp. 911-914
Citation: Y. Chiba et al., Possible involvement of G(i3) protein in augmented contraction of bronchial smooth muscle from antigen-induced airway hyperresponsive rats, BIOCH PHARM, 61(7), 2001, pp. 921-924
Authors:
Srinivasan, C
Williams, WM
Nagasawa, HT
Chen, TS
Citation: C. Srinivasan et al., Effects of 2(RS)-n-propylthiazolidine-4(R)-carboxylic acid on extrahepaticsulfhydryl levels in mice treated with acetaminophena, BIOCH PHARM, 61(7), 2001, pp. 925-931
Citation: Lm. Lichtenberger, Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited, BIOCH PHARM, 61(6), 2001, pp. 631-637
Authors:
Tronstad, KJ
Berge, K
Dyroy, E
Madsen, L
Berger, RK
Citation: Kj. Tronstad et al., Growth reduction in glioma cells after treatment with tetradecylthioaceticacid: changes in fatty acid metabolism and oxidative status, BIOCH PHARM, 61(6), 2001, pp. 639-649
Authors:
Brugger, R
Reichel, C
Alia, BG
Brune, K
Yamamoto, T
Tegeder, I
Geissinger, G
Citation: R. Brugger et al., Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics, BIOCH PHARM, 61(6), 2001, pp. 651-656
Authors:
Ding, BC
Witt, TL
Hukku, B
Heng, H
Zhang, L
Matherly, LH
Citation: Bc. Ding et al., Association of deletions and translocation of the reduced folate carrier gene with profound loss of gene expression in methotrexate-resistant K562 human erythroleukemia cells, BIOCH PHARM, 61(6), 2001, pp. 665-675
Authors:
Afanas'ev, IB
Ostrakhovitch, EA
Mikhal'chik, EV
Ibragimova, GA
Korkina, LG
Citation: Ib. Afanas'Ev et al., Enhancement of antioxidant and anti-inflammatory activities of bioflavonoid rutin by complexation with transition metals, BIOCH PHARM, 61(6), 2001, pp. 677-684
Citation: Z. Mazerska et al., Enzymatic activation of a new antitumour drug, 5-diethylaminoethylamino-8-hydroxyimidazoacridinone, C-1311, observed after its intercalation into DNA, BIOCH PHARM, 61(6), 2001, pp. 685-694